Dr. Dawn S. Eliashiv, MD

Dr. Eliashiv practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Eliashiv's NPI, 1144286162, was assigned on April 26, 2006. Dr. Eliashiv graduated from Tel Aviv University Sackler in 1985. Dr. Eliashiv holds California license A52594.

Dr. Eliashiv's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Eliashiv's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Eliashiv is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Eliashiv to 2 more hospitals, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eliashiv practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Eliashiv's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Eliashiv is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dr. Eliashiv is licensed in California.

Dmand AI lists epilepsy and seizures among the conditions Dr. Eliashiv treats.

CMS data shows 567 Medicare services from Dr. Eliashiv across 8 procedure codes in 2024, for 301 Medicare patients. Medicare paid $59,490 for them.

CMS counts 301 Medicare patients who saw Dr. Eliashiv in 2024. The largest group is under 65, with 101 patients. 72% of them have high cholesterol, and 71% have high blood pressure. 55% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eliashiv's median patient age at 42, with 48% women.

In 2024, Dr. Eliashiv wrote 1,847 Medicare Part D claims for 137 patients. 54% of them were for generic drugs. CMS names the drug for 1,756 of them, across 30 drugs with 11 or more claims each, at $2,344,326 in total drug cost. In 2023, CMS named 1,770 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Eliashiv for performance year 2024, reported as part of a group. Dr. Eliashiv accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eliashiv as offering telehealth.

Dmand AI links 11 papers to Dr. Eliashiv, published from 2014 to 2023. 2015 was the busiest year, with 3. Dr. Eliashiv's most frequent co-authors are Jerome Engel, MD, Brian D. Moseley, MD and Michael E. Jones, MD.

Dmand AI links Dr. Eliashiv to 1 clinical trial. Conditions studied include Epilepsy and Brain Diseases.

CMS Open Payments shows 1,003 general payments to Dr. Eliashiv from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Eisai Inc. paid the most, $144,553. It also lists 1 research payment totaling $754 in 2024.

Dmand AI lists 2 awards for Dr. Eliashiv, most recently Best Doctors in 2016.

Dr. Eliashiv graduated from Tel Aviv University Sackler in 1985. Dr. Eliashiv is a member of AAN, American Clinical Neurophysiology Society and AES.

Dr. Eliashiv is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.